Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach-Reference-Cited by-同舟云学术

Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach

Published:2022-04-26 Issue:5 Volume:16 Page:745-759
ISSN:2095-0217
Container-title:Frontiers of Medicine
language:en
Short-container-title:Front. Med.

Author:

Dai Liang,Xu Jingjuan,Liu Baocheng,Dang Yanqi,Wang Ruirui,Zhuang Lijie,Li Dong,Jiao Lulu,Wang Jianying,Zhang Lei,Zhong Linda L. D.,Zhou Wenjun,Ji Guang

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11684-021-0880-3.pdf

Reference55 articles.

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64(1): 73–84

2. Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Unexpected rapid increase in the burden of NAFLD in china from 2008 to 2018: a systematic review and meta-analysis. Hepatology 2019; 70(4): 1119–1133

3. Wu Y, Zheng Q, Zou B, Yeo YH, Li X, Li J, Xie X, Feng Y, Stave CD, Zhu Q, Cheung R, Nguyen MH. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int 2020; 14(2): 259–269

4. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107(5): 450–455

5. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Wester-backa J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87(7): 3023–3028

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gan-jiang-ling-zhu decoction improves steatohepatitis by regulating gut microbiota-mediated 12-tridecenoic acid inhibition;Frontiers in Pharmacology;2024-08-23

2. Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial;Phytomedicine;2024-07

3. Therapeutic effects of Lingguizhugan decoction in a rat model of high-fat diet-induced insulin resistance;World Journal of Diabetes;2024-06-15

4. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota;Microbiology Spectrum;2024-06-04

5. Integrated Pharmaco-Bioinformatics Approaches and Experimental Verification To Explore the Effect of Britanin on Nonalcoholic Fatty Liver Disease;ACS Omega;2024-02-09